| 304 |
Purified steviol glycosides with rebaudioside A and stevioside as the principal components |
Pending |
| 303 |
Rebaudioside A purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni |
Pending |
| 302 |
1,3-propanediol |
Pending |
| 301 |
Siraitia grosvenorii (Luo han guo) fruit extract |
Pending |
| 300 |
Trisodium diphosphate |
Pending |
| 299 |
Lycopene from Escherichia coli expressing lycopene biosynthetic enzymes |
At notifier's request, FDA ceased to evaluate the notice |
| 298 |
Silicon dioxide |
Pending |
| 297 |
Erythritol fatty acid esters |
Pending |
| 296 |
Lipase enzyme preparation from a genetically modified Aspergillus niger expressing a modified lipase gene from Fusarium spp. |
Pending |
| 295 |
Aqueous extract of Emblica officinalis |
Pending |
| 294 |
Haematococcus pluvialis extract containing astaxanthin esters |
Pending |
| 293 |
Glutathione |
Pending |
| 292 |
Cellulase enzyme preparation derived from a genetically modified strain of Myceliophthora thermophila |
FDA has no questions |
| 291 |
Crystalline lutein |
Pending |
| 290 |
L-arginine |
Pending |
| 289 |
Colicin E1 purified from Escherichia coli |
At notifier's request, FDA ceased to evaluate the notice |
| 288 |
Lactobacillus rhamnosus strain HN001 |
Pending |
| 287 |
Purified steviol glycosides with rebaudioside A and stevioside as the principal components |
FDA has no questions |
| 286 |
Galacto-oligosaccharides |
FDA has no questions |
| 285 |
Galacto-oligosaccharides |
FDA has no questions |
| 284 |
Bakers yeast mannoprotein |
FDA has no questions |
| 283 |
Stearidonic acid soybean oil |
FDA has no questions |
| 282 |
Rebaudioside A purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni |
FDA has no questions |
| 281 |
Lactobacillus rhamnosus strain HN001 produced in a milk-based medium |
FDA has no questions |
| 280 |
Whole and milled flaxseed |
FDA has no questions |
| 279 |
Phosphatidylserine derived from fish |
FDA has no questions |
| 278 |
Rebaudioside A purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni |
FDA has no questions |
| 277 |
Maltotetraohydrolase enzyme preparation from Bacillus licheniformis expressing a modified maltotetraohydrolase gene from Pseudomonas stutzeri |
FDA has no questions |
| 276 |
Dunaliella bardawil alga |
At notifier's request, FDA ceased to evaluate the notice |
| 275 |
Purified steviol glycosides with rebaudioside A as the principal component |
FDA has no questions |
| 274 |
Branching glycosyltransferase enzyme preparation from Bacillus subtilis expressing a branching glycosyltransferase gene from Rhodothermus obamensis |
FDA has no questions |
| 273 |
Baobab (Adansonia digitata) dried fruit pulp |
FDA has no questions |
| 272 |
Triple salt of magnesium, ammonium, and potassium chloride, hexahydrate |
FDA has no questions |
| 271 |
Ferrous ammonium phosphate |
FDA has no questions |
| 270 |
Polyglycerol polyricinoleic acid |
FDA has no questions |
| 269 |
Polyglycerol fatty acid esters with a degree of polymerization of 11 to 40 for the polyglycerol backbone |
FDA has no questions |
| 268 |
Bifidobacterium longum strain BB536 |
FDA has no questions |
| 267 |
Protein glutaminase enzyme preparation derived from Chryseobacterium proteolyticum |
FDA has no questions |
| 266 |
Polyglycerol polyricinoleate |
FDA has no questions |
| 265 |
Glycerophospholipid cholesterol acyltransferase (GCAT) enzyme preparation from Bacillus licheniformis expressing a modified GCAT gene from Aeromonas salmonicida subsp. salmonicida |
FDA has no questions |
| 264 |
Sweet lupin flour |
At notifier's request, FDA ceased to evaluate the notice |
| 263 |
Sweet lupin fiber |
At notifier's request, FDA ceased to evaluate the notice |
| 262 |
Sweet lupin protein |
At notifier's request, FDA ceased to evaluate the notice |
| 261 |
Oat hull fiber |
FDA has no questions |
| 260 |
High-selenium yeast |
FDA has no questions |
| 259 |
Catechins from green tea extract |
At notifier's request, FDA ceased to evaluate the notice |
| 258 |
Sucromalt |
FDA has no questions |
| 257 |
gamma-Amino butyric acid |
At notifier's request, FDA ceased to evaluate the notice |
| 256 |
High linolenic acid flaxseed oil |
FDA has no questions |
| 255 |
Bovine globulin |
FDA has no questions |